Your browser doesn't support javascript.
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity.
Gong, Shang Yu; Chatterjee, Debashree; Richard, Jonathan; Prévost, Jérémie; Tauzin, Alexandra; Gasser, Romain; Bo, Yuxia; Vézina, Dani; Goyette, Guillaume; Gendron-Lepage, Gabrielle; Medjahed, Halima; Roger, Michel; Côté, Marceline; Finzi, Andrés.
  • Gong SY; Centre de Recherche du CHUM, QC, H2X 0A9, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC, H3A 0G4, Canada.
  • Chatterjee D; Centre de Recherche du CHUM, QC, H2X 0A9, Canada.
  • Richard J; Centre de Recherche du CHUM, QC, H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, H2X 0A9, Canada.
  • Prévost J; Centre de Recherche du CHUM, QC, H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, H2X 0A9, Canada.
  • Tauzin A; Centre de Recherche du CHUM, QC, H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, H2X 0A9, Canada.
  • Gasser R; Centre de Recherche du CHUM, QC, H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, H2X 0A9, Canada.
  • Bo Y; Department of Biochemistry, Microbiology and Immunology, and Center for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
  • Vézina D; Centre de Recherche du CHUM, QC, H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, H2X 0A9, Canada.
  • Goyette G; Centre de Recherche du CHUM, QC, H2X 0A9, Canada.
  • Gendron-Lepage G; Centre de Recherche du CHUM, QC, H2X 0A9, Canada.
  • Medjahed H; Centre de Recherche du CHUM, QC, H2X 0A9, Canada.
  • Roger M; Centre de Recherche du CHUM, QC, H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, H2X 0A9, Canada; Laboratoire de Santé Publique du Québec, Institut Nationale de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC, H9X 3R5, Canada.
  • Côté M; Department of Biochemistry, Microbiology and Immunology, and Center for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
  • Finzi A; Centre de Recherche du CHUM, QC, H2X 0A9, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC, H3A 0G4, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, H2X 0A9, Canada. Electronic address: andres.finzi@umontreal
Virology ; 563: 134-145, 2021 11.
Article in English | MEDLINE | ID: covidwho-1401925
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Towards the end of 2020, multiple variants of concern (VOCs) and variants of interest (VOIs) have arisen from the original SARS-CoV-2 Wuhan-Hu-1 strain. Mutations in the Spike protein are highly scrutinized for their impact on transmissibility, pathogenesis and vaccine efficacy. Here, we contribute to the growing body of literature on emerging variants by evaluating the impact of single mutations on the overall antigenicity of selected variants and their binding to the ACE2 receptor. We observe a differential contribution of single mutants to the global variants phenotype related to ACE2 interaction and antigenicity. Using biolayer interferometry, we observe that enhanced ACE2 interaction is mostly modulated by a decrease in off-rate. Finally, we made the interesting observation that the Spikes from tested emerging variants bind better to ACE2 at 37°C compared to the D614G variant. Whether improved ACE2 binding at higher temperature facilitates emerging variants transmission remain to be demonstrated.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Virology Year: 2021 Document Type: Article Affiliation country: J.virol.2021.09.001

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Virology Year: 2021 Document Type: Article Affiliation country: J.virol.2021.09.001